US EditionFacet Life Sciences Announces Partnership with Nucleus for Regulatory Support
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Facet Life Sciences Announces Partnership with Nucleus for Regulatory Support
PHOENIXVILLE, PA — Facet Life Sciences, a firm specializing in regulatory guidance for life science companies, has announced its partnership with Nucleus, a leader in diagnostic and therapeutic radiopharmaceuticals. Facet will serve as Nucleus’ official regulatory partner, providing expertise in U.S. regulatory affairs and development support for innovative products in the radiopharmaceutical sector. Ken VanLuvanee, President & CEO of Facet Life…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
